Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS‐ACTS Substudy

BACKGROUND: The efficacy, safety, and ease of use of rivaroxaban may reduce anticoagulation‐treatment burden and improve nonvalvular atrial fibrillation (NVAF) patient satisfaction compared with vitamin K antagonists (VKAs). HYPOTHESIS: Transitioning from a VKA to rivaroxaban improves treatment sati...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Cardiol
Hlavní autoři: Coleman, Craig I., Haas, Sylvia, Turpie, Alexander G.G., Kuhls, Silvia, Hess, Susanne, Evers, Thomas, Amarenco, Pierre, Kirchhof, Paulus, Camm, A. John
Médium: Artigo
Jazyk:Inglês
Vydáno: Wiley Periodicals, Inc. 2016
Témata:
Clinical Investigations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6490868/
https://ncbi.nlm.nih.gov/pubmed/27362695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22565
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky